Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: 40 Hz Flickering for Insomnia in Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial is investigating 40 Hz flickering as a treatment for insomnia in Parkinson's disease patients, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jiangsu Province Nanjing Brain Hospital | Conditions: Parkinson Disease, Insomnia | NA | Status: NOT_YET_RECRUITING